Francesco Lauria

InstitutionUniversity of Siena Policlinico S Maria alle Scotte
AddressSiena
Italy
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 1 Covid-19 publications, with a maximum of 1 publications in May 2021
    All Publications
    Bar chart showing 103 publications over 14 distinct years, with a maximum of 15 publications in 2010
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Citations:    Fields:    Translation:HumansPHPublic Health
    2. Cencini E, Fabbri A, Lauria F, Bocchia M. Long-term efficacy and toxicity of rituximab plus fludarabine and mitoxantrone (R-FM) for gastric marginal zone lymphoma: a single-center experience and literature review. Ann Hematol. 2018 May; 97(5):821-829. PMID: 29340761.
      Citations:    Fields:    Translation:Humans
    3. Gozzetti A, Candi V, Fabbri A, Schiattone L, Cencini E, Lauria F, Frasconi A, Crupi R, Raspadori D, Papini G, Defina M, Bartalucci G, Bocchia M. Chemoimmunotherapy with oral low-dose fludarabine, cyclophosphamide and rituximab (old-FCR) as treatment for elderly patients with chronic lymphocytic leukaemia. Leuk Res. 2014 Aug; 38(8):891-5. PMID: 24934847.
      Citations: 3     Fields:    Translation:Humans
    4. Foà R, Del Giudice I, Cuneo A, Del Poeta G, Ciolli S, Di Raimondo F, Lauria F, Cencini E, Rigolin GM, Cortelezzi A, Nobile F, Callea V, Brugiatelli M, Massaia M, Molica S, Trentin L, Rizzi R, Specchia G, Di Serio F, Orsucci L, Ambrosetti A, Montillo M, Zinzani PL, Ferrara F, Morabito F, Mura MA, Soriani S, Peragine N, Tavolaro S, Bonina S, Marinelli M, De Propris MS, Starza ID, Piciocchi A, Alietti A, Runggaldier EJ, Gamba E, Mauro FR, Chiaretti S, Guarini A. Chlorambucil plus rituximab with or without maintenance rituximab as first-line treatment for elderly chronic lymphocytic leukemia patients. Am J Hematol. 2014 May; 89(5):480-6. PMID: 24415640.
      Citations: 35     Fields:    Translation:HumansCTClinical Trials
    5. Petrucci MT, Calabrese E, Levi A, Federico V, Ceccolini M, Rizzi R, Gozzetti A, Falco P, Lazzaro C, Martelli E, Boccadoro M, Lauria F, Liso V, Cavo M, Foa R. Cost of illness in patients with multiple myeloma in Italy: the CoMiM study. Tumori. 2013 Jul-Aug; 99(4):e193-202. PMID: 24326862.
      Citations: 6     Fields:    Translation:Humans
    6. Defina M, Ippoliti M, Gozzetti A, Abruzzese E, Castagnetti F, Crupi R, Tiribelli M, Breccia M, Salvucci M, Aprile L, Baratè C, Gozzini A, Rosti G, Lauria F, Bocchia M. Evaluation of residual CD34(+) Ph(+) progenitor cells in chronic myeloid leukemia patients who have complete cytogenetic response during first-line nilotinib therapy. Cancer. 2012 Nov 01; 118(21):5265-9. PMID: 22517301.
      Citations: 4     Fields:    Translation:HumansCells
    7. Ippoliti M, Defina M, Gozzini A, Baratè C, Aprile L, Pietrini A, Gozzetti A, Raspadori D, Lauria F, Bocchia M. Identification of a novel p190-derived breakpoint Peptide suitable for Peptide vaccine therapeutic approach in ph+ acute lymphoblastic leukemia patients. Leuk Res Treatment. 2012; 2012:150651. PMID: 23198152.
      Citations:    
    8. Bulian P, Rossi D, Forconi F, Del Poeta G, Bertoni F, Zucca E, Montillo M, Pozzato G, D'Arena G, Efremov DG, Marasca R, Lauria F, Gaidano G, Gattei V, Laurenti L. IGHV gene mutational status and 17p deletion are independent molecular predictors in a comprehensive clinical-biological prognostic model for overall survival prediction in chronic lymphocytic leukemia. J Transl Med. 2012 Jan 30; 10:18. PMID: 22289136.
      Citations: 8     Fields:    Translation:HumansCells
    9. Gozzetti A, Marchini E, Banchi B, Papini G, Defina M, Bocchia M, Lauria F. Extramedullary multifocal plasmacytoma relapse in multiple myeloma. Leuk Res. 2012 Jan; 36(1):e34-6. PMID: 21993312.
      Citations: 4     Fields:    Translation:Humans
    10. Mauro FR, Bandini G, Barosi G, Billio A, Brugiatelli M, Cuneo A, Lauria F, Liso V, Marchetti M, Meloni G, Montillo M, Zinzani P, Tura S. SIE, SIES, GITMO updated clinical recommendations for the management of chronic lymphocytic leukemia. Leuk Res. 2012 Apr; 36(4):459-66. PMID: 21885123.
      Citations: 1     Fields:    Translation:Humans
    11. Gozzetti A, Cerase A, Lotti F, Rossi D, Palumbo A, Petrucci MT, Patriarca F, Nozzoli C, Cavo M, Offidani M, Floridia M, Berretta S, Vallone R, Musto P, Lauria F, Marchini E, Fabbri A, Oliva S, Zamagni E, Sapienza FG, Ballanti S, Mele G, Galli M, Pirrotta MT, Di Raimondo F. Extramedullary intracranial localization of multiple myeloma and treatment with novel agents: a retrospective survey of 50 patients. Cancer. 2012 Mar 15; 118(6):1574-84. PMID: 21932386.
      Citations: 35     Fields:    Translation:Humans
    12. Gozzetti A, Cerase A, Crupi R, Raspadori D, Defina M, Bocchia M, Lauria F. A central nervous system CD56 positive multiple myeloma patient with a t(11;14) (q11;q32): a case report. Leuk Res. 2011 Nov; 35(11):e206-8. PMID: 21767877.
      Citations: 1     Fields:    Translation:HumansCells
    13. Malagola M, Skert C, Vignetti M, Piciocchi A, Martinelli G, Alimena G, Mecucci C, Testoni N, Iacobucci I, Clavio M, Gobbi M, Candoni A, Damiani D, Bocchia M, Lauria F, Zaccaria A, Mazza P, Visani G, Peli A, Colombi C, Cancelli V, Mancini M, Foà R, Martelli M, Cantore N, Di Raimondo F, Petrini M, De Fabritiis P, Fioritoni G, Nobile F, Fabbiano F, Specchia G, Baccarani M, Lo Coco F, Amadori S, Mandelli F, Russo D. A simple prognostic scoring system for newly diagnosed cytogenetically normal acute myeloid leukemia: retrospective analysis of 530 patients. Leuk Lymphoma. 2011 Dec; 52(12):2329-35. PMID: 21745171.
      Citations: 2     Fields:    Translation:Humans
    14. Cencini E, Sozzi E, Sicuranza A, Fabbri A, Raspadori D, Lauria F, Forconi F. A pilot monocentric analysis of efficacy and safety of Fludarabine-Campath combination (Flucam) as first line treatment in elderly patients with chronic lymphocytic leukaemia and Tp53 disfunction. Br J Haematol. 2011 Jul; 154(2):271-4. PMID: 21521181.
      Citations: 2     Fields:    Translation:Humans
    15. Lauria F, Cencini E, Forconi F. Alternative methods of cladribine administration. Leuk Lymphoma. 2011 Jun; 52 Suppl 2:34-7. PMID: 21504286.
      Citations: 7     Fields:    Translation:Humans
    16. Else M, Dearden CE, Matutes E, Forconi F, Lauria F, Ahmad H, Kelly S, Liyanage A, Ratnayake V, Shankari J, Whalley I, Catovsky D. Rituximab with pentostatin or cladribine: an effective combination treatment for hairy cell leukemia after disease recurrence. Leuk Lymphoma. 2011 Jun; 52 Suppl 2:75-8. PMID: 21504288.
      Citations: 17     Fields:    Translation:Humans
    17. Forconi F, Cencini E, Sozzi E, Sicuranza A, Raspadori D, Lauria F. Insight into the behavior of hairy cell leukemia by immunogenetic analysis. Leuk Lymphoma. 2011 Jun; 52 Suppl 2:103-7. PMID: 21504291.
      Citations: 3     Fields:    Translation:Humans
    18. Gozzetti A, Coviello G, Fabbri A, Della Corte R, Bocchia M, Defina M, Lauria F. Unusual localizations of plasmacytoma. Leuk Res. 2011 Jul; 35(7):e104-5. PMID: 21397945.
      Citations:    Fields:    Translation:Humans
    19. Sozzi E, Amato T, Sahota SS, Nuti S, Raspadori D, Sicuranza A, Cencini E, Tosi P, Lauria F, Forconi F. Lack of allelic exclusion by secondary rearrangements of tumour B-cell receptor light chains in hairy cell leukaemia. Hematol Oncol. 2011 Mar; 29(1):31-7. PMID: 20658474.
      Citations: 4     Fields:    Translation:Humans
    20. Rossi D, Rasi S, Di Rocco A, Fabbri A, Forconi F, Gloghini A, Bruscaggin A, Franceschetti S, Fangazio M, De Paoli L, Bruna R, Capello D, Chiappella A, Lobetti Bodoni C, Giachelia M, Tisi MC, Pogliani EM, Lauria F, Ladetto M, Hohaus S, Martelli M, Vitolo U, Carbone A, Foà R, Gaidano G. The host genetic background of DNA repair mechanisms is an independent predictor of survival in diffuse large B-cell lymphoma. Blood. 2011 Feb 24; 117(8):2405-13. PMID: 21156845.
      Citations: 12     Fields:    Translation:HumansCells
    21. Forconi F, Cencini E, Sicuranza A, Sozzi E, Lauria F. Molecular insight into the biology and clinical course of hairy cell leukemia utilizing immunoglobulin gene analysis. Leuk Lymphoma. 2011 Jan; 52(1):15-23. PMID: 21133731.
      Citations: 5     Fields:    Translation:Humans
    22. Molica S, Mauro FR, Giannarelli D, Lauria F, Cortelezzi A, Brugiatelli M, Liso V, Cuneo A, Foà R. Differentiating chronic lymphocytic leukemia from monoclonal B-lymphocytosis according to clinical outcome: on behalf of the GIMEMA chronic lymphoproliferative diseases working group. Haematologica. 2011 Feb; 96(2):277-83. PMID: 20971821.
      Citations: 15     Fields:    Translation:HumansCells
    23. Rigacci L, Fabbri A, Puccini B, Chitarrelli I, Chiappella A, Vitolo U, Levis A, Lauria F, Bosi A. Oxaliplatin-based chemotherapy (dexamethasone, high-dose cytarabine, and oxaliplatin)±rituximab is an effective salvage regimen in patients with relapsed or refractory lymphoma. Cancer. 2010 Oct 01; 116(19):4573-9. PMID: 20572029.
      Citations: 7     Fields:    Translation:Humans
    24. Bocchia M, Defina M, Aprile L, Ippoliti M, Crupi R, Rondoni M, Gozzetti A, Lauria F. Complete molecular response in CML after p210 BCR-ABL1-derived peptide vaccination. Nat Rev Clin Oncol. 2010 Oct; 7(10):600-3. PMID: 20808301.
      Citations: 14     Fields:    Translation:HumansPHPublic Health
    25. Fabbri A, Gozzetti A, Forconi F, Lauria F. Predicting the clinical course of Hodgkin lymphoma. Nat Rev Clin Oncol. 2010 Aug; 7(8):doi:10.1038/nrclinonc.2010.36-c1. PMID: 20700915.
      Citations:    Fields:    Translation:HumansCells
    26. Bulian P, Tarnani M, Rossi D, Forconi F, Del Poeta G, Bertoni F, Zucca E, Montillo M, Pozzato G, Deaglio S, D'Arena G, Efremov D, Marasca R, Lauria F, Gattei V, Gaidano G, Laurenti L. Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia. Hematol Oncol. 2011 Jun; 29(2):91-9. PMID: 20669154.
      Citations: 8     Fields:    Translation:Humans
    27. Gozzetti A, Crupi R, Rondoni M, Defina M, Bocchia M, Pietrini A, Raspadori D, Lauria F. A der(1)t(1;21)(p36.3;q22) in a patient with acute myelogenous leukemia M2. Acta Haematol. 2010; 124(1):44-5. PMID: 20606416.
      Citations:    Fields:    Translation:Humans
    28. Gozzetti A, Defina M, Bocchia M, Fabbri A, Marchini E, Chitarrelli I, Lauria F. Safety and efficacy of bortezomib, melphalan and low doses dexamethasone (VM-dex) in newly diagnosed patients with multiple myeloma. Leuk Res. 2010 Nov; 34(11):e288-9. PMID: 20557933.
      Citations: 1     Fields:    Translation:Humans
    29. Breccia M, Bocchia M, Cannella L, Defina M, Ippoliti M, Loglisci G, Santopietro M, Lauria F, Alimena G. Reduction of imatinib dose and persistence of complete molecular response after p210 multipeptide vaccine in chronic myeloid leukaemia treated with dose escalation for acquired resistance. Br J Haematol. 2010 Jul; 150(2):240-2. PMID: 20346015.
      Citations: 2     Fields:    Translation:Humans
    30. Amadori S, Suciu S, Selleslag D, Stasi R, Alimena G, Baila L, Rizzoli V, Borlenghi E, Gaidano G, Magro D, Torelli G, Muus P, Venditti A, Cacciola E, Lauria F, Vignetti M, de Witte T. Randomized trial of two schedules of low-dose gemtuzumab ozogamicin as induction monotherapy for newly diagnosed acute myeloid leukaemia in older patients not considered candidates for intensive chemotherapy. A phase II study of the EORTC and GIMEMA leukaemia groups (AML-19). Br J Haematol. 2010 May; 149(3):376-82. PMID: 20230405.
      Citations: 20     Fields:    Translation:HumansCTClinical Trials
    31. Gozzetti A, Defina M, Bocchia M, Lauria F. Hyperlipidemic myeloma. Ann Hematol. 2010 Sep; 89(9):939-40. PMID: 20127090.
      Citations:    Fields:    Translation:Humans
    32. Gozzetti A, Fabbri A, Oliva S, Marchini E, Bocchia M, Defina M, Lauria F. Weekly bortezomib, pegylated liposomal doxorubicin, and dexamethasone is a safe and effective therapy for elderly patients with relapsed/refractory multiple myeloma. Clin Lymphoma Myeloma Leuk. 2010 Feb; 10(1):68-72. PMID: 20223732.
      Citations: 5     Fields:    Translation:Humans
    33. Gozzetti A, Crupi R, Rondoni M, Daviddi B, Defina M, Bocchia M, Pietrini A, Raspadori D, Lauria F. Translocation(X;2)(q26;q11.2) in a patient with acute myeloid leukemia M2 evolved from essential thrombocytemia. Cancer Genet Cytogenet. 2010 Feb; 197(1):84-5. PMID: 20113843.
      Citations:    Fields:    Translation:HumansCells
    34. Capitani N, Lucherini OM, Sozzi E, Ferro M, Giommoni N, Finetti F, De Falco G, Cencini E, Raspadori D, Pelicci PG, Lauria F, Forconi F, Baldari CT. Impaired expression of p66Shc, a novel regulator of B-cell survival, in chronic lymphocytic leukemia. Blood. 2010 May 06; 115(18):3726-36. PMID: 20061561.
      Citations: 16     Fields:    Translation:HumansAnimalsCells
    35. Molica S, Mauro FR, Callea V, Giannarelli D, Lauria F, Rotoli B, Cortelezzi A, Liso V, Foà R. The utility of a prognostic index for predicting time to first treatment in early chronic lymphocytic leukemia: the GIMEMA experience. Haematologica. 2010 Mar; 95(3):464-9. PMID: 19903673.
      Citations: 10     Fields:    Translation:Humans
    36. Defina M, Rondoni M, Gozzetti A, Aprile L, Chitarrelli I, Fabbri A, Lauria F, Bocchia M. Lenalidomide on alternative days is effective in myelodysplastic syndrome with 5q- deletion. Br J Haematol. 2010 Feb; 148(3):483-4. PMID: 19874309.
      Citations: 4     Fields:    Translation:HumansCellsCTClinical Trials
    37. Lauria F, Forconi F. Combination therapies to improve the long-term outcome in hairy cell leukemia. Leuk Lymphoma. 2009 Oct; 50 Suppl 1:18-22. PMID: 19814693.
      Citations: 4     Fields:    Translation:Humans
    38. Forconi F, Sozzi E, Cencini E, Zaja F, Intermesoli T, Stelitano C, Rigacci L, Gherlinzoni F, Cantaffa R, Baraldi A, Gallamini A, Zaccaria A, Pulsoni A, Gobbi M, Tassi M, Raspadori D, Leoncini L, Rinaldi A, Sabattini E, Bertoni F, Pileri SA, Lauria F. Hairy cell leukemias with unmutated IGHV genes define the minor subset refractory to single-agent cladribine and with more aggressive behavior. Blood. 2009 Nov 19; 114(21):4696-702. PMID: 19667403.
      Citations: 24     Fields:    Translation:HumansCellsCTClinical Trials
    39. Gozzetti A, Crupi R, Defina M, Bocchia M, Raspadori D, Lauria F. Isolated deletion of 6q in a patient with myelodysplastic syndrome. Cancer Genet Cytogenet. 2009 Jul; 192(1):51. PMID: 19480939.
      Citations: 1     Fields:    Translation:HumansCells
    40. Rossi D, Sozzi E, Puma A, De Paoli L, Rasi S, Spina V, Gozzetti A, Tassi M, Cencini E, Raspadori D, Pinto V, Bertoni F, Gattei V, Lauria F, Gaidano G, Forconi F. The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors. Br J Haematol. 2009 Jun; 146(1):64-75. PMID: 19438485.
      Citations: 40     Fields:    Translation:HumansCells
    41. Else M, Dearden CE, Matutes E, Garcia-Talavera J, Rohatiner AZ, Johnson SA, O'Connor NT, Haynes A, Osuji N, Forconi F, Lauria F, Catovsky D. Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis. Br J Haematol. 2009 Jun; 145(6):733-40. PMID: 19344416.
      Citations: 69     Fields:    Translation:Humans
    42. Rossi D, Cerri M, Deambrogi C, Sozzi E, Cresta S, Rasi S, De Paoli L, Spina V, Gattei V, Capello D, Forconi F, Lauria F, Gaidano G. The prognostic value of TP53 mutations in chronic lymphocytic leukemia is independent of Del17p13: implications for overall survival and chemorefractoriness. Clin Cancer Res. 2009 Feb 01; 15(3):995-1004. PMID: 19188171.
      Citations: 91     Fields:    Translation:HumansCells
    43. Forconi F, Fabbri A, Lenoci M, Sozzi E, Gozzetti A, Tassi M, Raspadori D, Lauria F. Low-dose oral fludarabine plus cyclophosphamide in elderly patients with untreated and relapsed or refractory chronic lymphocytic Leukaemia. Hematol Oncol. 2008 Dec; 26(4):247-51. PMID: 18642397.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    44. Bomben R, Dal Bo M, Capello D, Forconi F, Maffei R, Laurenti L, Rossi D, Del Principe MI, Zucchetto A, Bertoni F, Rossi FM, Bulian P, Cattarossi I, Ilariucci F, Sozzi E, Spina V, Zucca E, Degan M, Lauria F, Del Poeta G, Efremov DG, Marasca R, Gaidano G, Gattei V. Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study. Br J Haematol. 2009 Feb; 144(4):492-506. PMID: 19036101.
      Citations: 30     Fields:    Translation:HumansCells
    45. Forconi F, Rinaldi A, Kwee I, Sozzi E, Raspadori D, Rancoita PM, Scandurra M, Rossi D, Deambrogi C, Capello D, Zucca E, Marconi D, Bomben R, Gattei V, Lauria F, Gaidano G, Bertoni F. Genome-wide DNA analysis identifies recurrent imbalances predicting outcome in chronic lymphocytic leukaemia with 17p deletion. Br J Haematol. 2008 Nov; 143(4):532-6. PMID: 18752589.
      Citations: 25     Fields:    Translation:HumansCells
    46. Malagola M, Peli A, Damiani D, Candoni A, Tiribelli M, Martinelli G, Piccaluga PP, Paolini S, De Rosa F, Lauria F, Bocchia M, Gobbi M, Pierri I, Zaccaria A, Zuffa E, Mazza P, Priccolo G, Gugliotta L, Bonini A, Visani G, Skert C, Bergonzi C, Roccaro AM, Filì C, Fanin R, Baccarani M, Russo D. Incidence of bacterial and fungal infections in newly diagnosed acute myeloid leukaemia patients younger than 65 yr treated with induction regimens including fludarabine: retrospective analysis of 224 cases. Eur J Haematol. 2008 Nov; 81(5):354-63. PMID: 18637030.
      Citations: 8     Fields:    Translation:Humans
    47. Cairo AG, Quaranta G, Laurenti P, Bruno S, La Torre G, Donno S, Geraci S, Annunziata F, Attanasio G, Molina R, Milano R, Saggion M, Lauria F, Gualano G, Delogu G, Ardito F, Pirronti T, Filograna E, De Lorenzis A, Alvaro G, Ielo S, Ricciardi G. [An integrated model for the evaluation and risk management of tuberculosis infection and active tuberculosis in homeless people in the city of Rome (Italy)]. Ig Sanita Pubbl. 2008 Jul-Aug; 64(4):431-45. PMID: 18985080.
      Citations:    Fields:    Translation:HumansPHPublic Health
    48. Cavazzini F, Hernandez JA, Gozzetti A, Russo Rossi A, De Angeli C, Tiseo R, Bardi A, Tammiso E, Crupi R, Lenoci MP, Forconi F, Lauria F, Marasca R, Maffei R, Torelli G, Gonzalez M, Martin-Jimenez P, Maria Hernandez J, Rigolin GM, Cuneo A. Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis. Br J Haematol. 2008 Aug; 142(4):529-37. PMID: 18547320.
      Citations: 20     Fields:    Translation:HumansCells
    49. Gozzetti A, Gennari L, Merlotti D, Salvadori S, De Paola V, Avanzati A, Franci B, Marchini E, Tozzi M, Campagna MS, Nuti R, Lauria F, Martini G. The effects of zoledronic acid on serum lipids in multiple myeloma patients. Calcif Tissue Int. 2008 Apr; 82(4):258-62. PMID: 18418538.
      Citations: 5     Fields:    Translation:Humans
    50. Forconi F, Poretti G, Kwee I, Sozzi E, Rossi D, Rancoita PM, Capello D, Rinaldi A, Zucca E, Raspadori D, Spina V, Lauria F, Gaidano G, Bertoni F. High density genome-wide DNA profiling reveals a remarkably stable profile in hairy cell leukaemia. Br J Haematol. 2008 May; 141(5):622-30. PMID: 18397341.
      Citations: 6     Fields:    Translation:Humans
    51. Forconi F, Sozzi E, Rossi D, Sahota SS, Amato T, Raspadori D, Trentin L, Leoncini L, Gaidano G, Lauria F. Selective influences in the expressed immunoglobulin heavy and light chain gene repertoire in hairy cell leukemia. Haematologica. 2008 May; 93(5):697-705. PMID: 18387977.
      Citations: 13     Fields:    Translation:HumansCells
    52. Pirrotta MT, Gozzetti A, Cerase A, Bucalossi A, Bocchia M, Defina M, Lauria F. Unusual discordant responses in two multiple myeloma patients during bortezomib treatment. Onkologie. 2008 Feb; 31(1-2):45-7. PMID: 18268398.
      Citations: 3     Fields:    Translation:HumansCells
    53. Gozzetti A, Bocchia M, Crupi R, Calabrese S, Pirrotta MT, Raspadori D, Defina M, Algeri R, Lauria F. Concomitant chronic myeloid leukemia and chronic lymphocytic leukemia: a different clonal origin shown by molecular cytogenetics. Cancer Genet Cytogenet. 2008 Jan 01; 180(1):83-4. PMID: 18068541.
      Citations: 1     Fields:    Translation:HumansCells
    54. Forconi F, Toraldo F, Sozzi E, Amato T, Raspadori D, Lauria F. Complete molecular remission induced by concomitant cladribine--rituximab treatment in a case of multi-resistant hairy cell leukemia. Leuk Lymphoma. 2007 Dec; 48(12):2441-3. PMID: 18067021.
      Citations: 4     Fields:    Translation:HumansCells
    55. Piccaluga PP, Malagola M, Rondoni M, Arpinati M, Paolini S, Candoni A, Fanin R, Messa E, Pirrotta MT, Lauria F, Visani G, Alberti D, Rancati F, Vinaccia V, Russo D, Saglio G, Baccarani M, Martinelli G. Imatinib mesylate in the treatment of newly diagnosed or refractory/resistant c-KIT positive acute myeloid leukemia. Results of an Italian Multicentric Phase II Study. Haematologica. 2007 Dec; 92(12):1721-2. PMID: 18056005.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    56. Else M, Osuji N, Forconi F, Dearden C, Del Giudice I, Matutes E, Wotherspoon A, Lauria F, Catovsky D. The role of rituximab in combination with pentostatin or cladribine for the treatment of recurrent/refractory hairy cell leukemia. Cancer. 2007 Nov 15; 110(10):2240-7. PMID: 17886250.
      Citations: 9     Fields:    Translation:Humans
    57. Fabbri A, Lenoci M, Gozzetti A, Chitarrelli I, Olcese F, Raspadori D, Gobbi M, Lauria F. Low-dose oral fludarabine plus cyclophosphamide as first-line treatment in elderly patients with indolent non-Hodgkin lymphoma. Br J Haematol. 2007 Oct; 139(1):90-3. PMID: 17854311.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    58. Gozzetti A, Calabrese S, Raspadori D, Crupi R, Tassi M, Bocchia M, Fabbri A, Lauria F. Concomitant t(4;11) and t(1;19) in a patient with biphenotypic acute leukemia. Cancer Genet Cytogenet. 2007 Aug; 177(1):81-2. PMID: 17693199.
      Citations: 1     Fields:    Translation:HumansCells
    59. Gozzetti A, Calabrese S, Crupi R, Zaja F, Tozzuoli D, Tassi M, Raspadori D, Lenoci M, Lauria F. Trisomy 8 in chronic lymphocytic leukemia: a report of two cases. Cancer Genet Cytogenet. 2007 Jun; 175(2):175-6. PMID: 17556077.
      Citations:    Fields:    Translation:HumansCells
    60. Gozzetti A, Calabrese S, Crupi R, Tozzuoli D, Fabbri A, Bocchia M, Pirrotta MT, Defina M, Lauria F. Deletion 9q in a patient with concomitant myelodysplasia and non-Hodgkin lymphoma. Cancer Genet Cytogenet. 2007 Jun; 175(2):177. PMID: 17556078.
      Citations:    Fields:    Translation:HumansCells
    61. Pirrotta MT, Bocchia M, Bucalossi A, Defina M, Forconi F, Gozzetti A, Lauria F. Pilot study of gemtuzumab ozogamicin (GO), fludarabine, cytarabine and idarubicin combined regimen (GO-FLAI) as first-line induction therapy plus GO alone as consolidation therapy for elderly acute myeloid leukemia patients. Acta Haematol. 2007; 118(1):7-9. PMID: 17389781.
      Citations: 1     Fields:    Translation:Humans
    62. Gozzetti A, Cerase A, Tarantino A, Fabbri A, Bocchia M, Pirrotta MT, Lauria F. Multiple myeloma involving the cavernous sinus: a report of 3 cases and response to bortezomib. Clin Lymphoma Myeloma. 2007 Mar; 7(5):376-8. PMID: 17562250.
      Citations: 9     Fields:    Translation:Humans
    63. Gozzetti A, Bocchia M, Calabrese S, Pirrotta MT, Crupi R, Raspadori D, Lauria F. Promyelocytic blast crisis of chronic myelogenous leukemia during imatinib treatment. Acta Haematol. 2007; 117(4):236-7. PMID: 17308370.
      Citations: 2     Fields:    Translation:Humans
    64. Malagola M, Damiani D, Martinelli G, Michelutti A, Cesana B, Vivo AD, Piccaluga PP, Ottaviani E, Candoni A, Geromin A, Tiribelli M, Fanin R, Testoni N, Lauria F, Bocchia M, Gobbi M, Pierri I, Zaccaria A, Zuffa E, Mazza P, Priccolo G, Gugliotta L, Bonini A, Visani G, Skert C, Bergonzi C, Roccaro AM, Filí C, Baccarani M, Russo D. Case-control study of multidrug resistance phenotype and response to induction treatment including or not fludarabine in newly diagnosed acute myeloid leukaemia patients. Br J Haematol. 2007 Jan; 136(1):87-95. PMID: 17222198.
      Citations: 1     Fields:    Translation:Humans
    65. Brugiatelli M, Bandini G, Barosi G, Lauria F, Liso V, Marchetti M, Mauro FR, Meloni G, Zinzani PL, Tura S. Management of chronic lymphocytic leukemia: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation. Haematologica. 2006 Dec; 91(12):1662-73. PMID: 17145603.
      Citations: 7     Fields:    Translation:Humans
    66. Martini G, Gozzetti A, Gennari L, Avanzati A, Nuti R, Lauria F. The effect of zoledronic acid on serum osteoprotegerin in early stage multiple myeloma. Haematologica. 2006 Dec; 91(12):1720-1. PMID: 17145616.
      Citations: 5     Fields:    Translation:Humans
    67. Bocchia M, Forconi F, Lauria F. Emerging drugs in chronic myelogenous leukaemia. Expert Opin Emerg Drugs. 2006 Nov; 11(4):651-64. PMID: 17064224.
      Citations: 2     Fields:    Translation:Humans
    68. Mazzotta S, Guerranti R, Gozzetti A, Bucalossi A, Bocchia M, Sammassimo S, Petralia S, Ogueli GI, Lauria F. Increased serum lactate dehydrogenase isoenzymes in Ph-negative chronic myeloproliferative diseases: a metabolic adaptation? Hematology. 2006 Aug; 11(4):239-44. PMID: 17178662.
      Citations: 4     Fields:    Translation:HumansCells
    69. Gozzetti A, Calabrese S, Crupi R, Tozzuoli D, Bocchia M, Fabbri A, Pirrotta MT, Sammassimo S, Defina M, Lauria F. Trisomy 22 as sole cytogenetic abnormality in acute monoblastic leukemia (M5b). Cancer Genet Cytogenet. 2006 Aug; 169(1):86. PMID: 16875946.
      Citations:    Fields:    Translation:HumansCells
    70. Marotta G, Frassoldati A, Zinzani P, Annino L, Brugiatelli M, Ambrosetti A, Lenoci M, Federico M, Foa R, Lauria F. Role of interferon-alpha administration after 2-deoxycoformycin in the treatment of hairy cell leukemia patients. Eur J Haematol. 2006 Aug; 77(2):109-13. PMID: 16856905.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    71. Gozzetti A, Crupi R, Tozzuoli D, Calabrese S, Bocchia M, Pirrotta MT, Raspadori D, Lauria F. Trisomy 13 in a patient with acute myeloid leukemia M0 and unusual durable remission. Cancer Genet Cytogenet. 2006 Jun; 167(2):182. PMID: 16737922.
      Citations:    Fields:    Translation:HumansCells
    72. Iacobucci I, Saglio G, Rosti G, Testoni N, Pane F, Amabile M, Poerio A, Soverini S, Bassi S, Cilloni D, Bassan R, Breccia M, Lauria F, Izzo B, Merante S, Frassoni F, Paolini S, Montefusco E, Baccarani M, Martinelli G. Achieving a major molecular response at the time of a complete cytogenetic response (CCgR) predicts a better duration of CCgR in imatinib-treated chronic myeloid leukemia patients. Clin Cancer Res. 2006 May 15; 12(10):3037-42. PMID: 16707599.
      Citations: 30     Fields:    Translation:HumansCTClinical Trials
    73. Fabbri A, Gozzetti A, Lazzi S, Lenoci M, D'Amuri A, Leoncini L, Lauria F. Activity of rituximab monotherapy in refractory splenic marginal zone lymphoma complicated with autoimmune hemolytic anemia. Clin Lymphoma Myeloma. 2006 May; 6(6):496-9. PMID: 16796783.
      Citations: 5     Fields:    Translation:Humans
    74. Mazzotta S, Gozzetti A, Pirrotta MT, Bocchia M, Sammassimo S, Bucalossi A, Lauria F. Low-dose thalidomide-induced agranulocytosis in a multiple myeloma patient treated at diagnosis. Leuk Lymphoma. 2005 Dec; 46(12):1837-8. PMID: 16263590.
      Citations: 1     Fields:    Translation:Humans
    75. Russo D, Malagola M, de Vivo A, Fiacchini M, Martinelli G, Piccaluga PP, Damiani D, Candoni A, Michielutti A, Castelli M, Testoni N, Ottaviani E, Rondoni M, Pricolo G, Mazza P, Zuffa E, Zaccaria A, Raspadori D, Bocchia M, Lauria F, Bonini A, Avanzini P, Gugliotta L, Visani G, Fanin R, Baccarani M. Multicentre phase III trial on fludarabine, cytarabine (Ara-C), and idarubicin versus idarubicin, Ara-C and etoposide for induction treatment of younger, newly diagnosed acute myeloid leukaemia patients. Br J Haematol. 2005 Oct; 131(2):172-9. PMID: 16197446.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    76. Marotta G, Tozzi M, Sammassimo S, Defina M, Raspadori D, Gozzetti A, Lauria F. Complete resolution of hepatic aspergillosis after non-myeloablative hematopoietic stem cell transplantation in a patient with acute myeloid leukemia. Hematology. 2005 Oct; 10(5):383-6. PMID: 16273726.
      Citations: 2     Fields:    Translation:Humans
    77. Bucaneve G, Micozzi A, Menichetti F, Martino P, Dionisi MS, Martinelli G, Allione B, D'Antonio D, Buelli M, Nosari AM, Cilloni D, Zuffa E, Cantaffa R, Specchia G, Amadori S, Fabbiano F, Deliliers GL, Lauria F, Foà R, Del Favero A. Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. N Engl J Med. 2005 Sep 08; 353(10):977-87. PMID: 16148283.
      Citations: 127     Fields:    Translation:HumansCTClinical Trials
    78. Pirrotta MT, Bucalossi A, Forconi F, Gozzetti A, Bocchia M, Mazzotta S, Sammassimo S, Lauria F. Massive intravascular hemolysis: a fatal complication of Clostridium perfringens septicemia in a patient with acute lymphoblastic leukemia. Leuk Lymphoma. 2005 May; 46(5):793. PMID: 16019522.
      Citations: 3     Fields:    Translation:HumansCells
    79. Molica S, Mauro FR, Callea V, Gentile M, Giannarelli D, Lopez M, Lauria F, Rotoli B, Montanaro M, Cortelezzi A, Liso V, Mandelli F, Foa R. A gender-based score system predicts the clinical outcome of patients with early B-cell chronic lymphocytic leukemia. Leuk Lymphoma. 2005 Apr; 46(4):553-60. PMID: 16032778.
      Citations: 11     Fields:    Translation:Humans
    80. Pirrotta MT, Bucalossi A, Forconi F, Bocchia M, Mazzotta S, Sammassimo S, Gozzetti A, Lauria F. Thrombotic thrombocytopenic purpura secondary to an occult adenocarcinoma. Oncologist. 2005 Apr; 10(4):299-300. PMID: 15821250.
      Citations: 3     Fields:    Translation:Humans
    81. Forconi F, Raspadori D, Lenoci M, Lauria F. Absence of surface CD27 distinguishes hairy cell leukemia from other leukemic B-cell malignancies. Haematologica. 2005 Feb; 90(2):266-8. PMID: 15710587.
      Citations: 6     Fields:    Translation:HumansCells
    82. Malagola M, Martinelli G, Rondoni M, Paolini S, Gaitani S, Arpinati M, Piccaluga PP, Amabile M, Basi C, Ottaviani E, Candoni A, Gottardi E, Cilloni D, Bocchia M, Saglio G, Lauria F, Fanin R, Visani G, Marrè MC, Maderna M, Rancati F, Vinaccia V, Russo D, Baccarani M. Imatinib mesylate in the treatment of c-kit-positive acute myeloid leukemia: is this the real target? Blood. 2005 Jan 15; 105(2):904; author reply 905. PMID: 15632213.
      Citations: 2     Fields:    Translation:Humans
    83. Gozzetti A, Crupi R, Tozzuoli D, Fabbri A, Bocchia M, Lauria F. Trisomy 13 in a patient with idiopathic myelofibrosis. Cancer Genet Cytogenet. 2005 Jan 15; 156(2):185. PMID: 15642403.
      Citations:    Fields:    Translation:HumansCells
    84. Rambaldi A, Carlotti E, Oldani E, Della Starza I, Baccarani M, Cortelazzo S, Lauria F, Arcaini L, Morra E, Pulsoni A, Rigacci L, Rupolo M, Zaja F, Zinzani PL, Barbui T, Foa R. Quantitative PCR of bone marrow BCL2/IgH+ cells at diagnosis predicts treatment response and long-term outcome in follicular non-Hodgkin lymphoma. Blood. 2005 May 01; 105(9):3428-33. PMID: 15637137.
      Citations: 13     Fields:    Translation:HumansCells
    85. Serraino D, Bidoli E, Piselli P, Angeletti C, Bruzzone S, Pappagallo M, Puro V, Girardi E, Lauria F, Ippolito G. [Time trends in infectious disease mortality in Italy: 1969-1999]. Epidemiol Prev. 2004 Nov-Dec; 28(6):322-9. PMID: 15792154.
      Citations: 1     Fields:    Translation:Humans
    86. Gozzetti A, Tozzuoli D, Crupi R, Bocchia M, Mazzotta S, Raspadori D, Lauria F. A case of i(11)(q10) as sole cytogenetic abnormality in a patient with acute lymphoblastic leukemia. Cancer Genet Cytogenet. 2004 Oct 15; 154(2):193-4. PMID: 15474162.
      Citations:    Fields:    Translation:HumansCells
    87. Gozzetti A, Tozzuoli D, Crupi R, Bocchia M, Mazzotta S, Lauria F. Effect of 5637 conditioned medium (CM) on the mitotic index in the cytogenetic evaluation of myeloproliferative disorders. Ann Genet. 2004 Oct-Dec; 47(4):432-4. PMID: 15581844.
      Citations:    Fields:    Translation:HumansCells
    88. Gozzetti A, Crupi R, Tozzuoli D, Raspadori D, Forconi F, Lauria F. Molecular cytogenetic analysis of B-CLL patients with aggressive disease. Hematology. 2004 Oct-Dec; 9(5-6):383-5. PMID: 15763978.
      Citations: 3     Fields:    Translation:HumansCells
    89. Gozzetti A, Marotta G, Lenoci M, Crupi R, Tozzuoli D, Calabrese S, Forconi F, Fabbri A, Lauria F. Trisomy 12 and t(14;22)(q32;q11) in a patient with B-cell chronic lymphocytic leukemia. Hematology. 2004 Oct-Dec; 9(5-6):405-7. PMID: 15763981.
      Citations: 1     Fields:    Translation:HumansCells
    90. Forconi F, Sahota SS, Raspadori D, Ippoliti M, Babbage G, Lauria F, Stevenson FK. Hairy cell leukemia: at the crossroad of somatic mutation and isotype switch. Blood. 2004 Nov 15; 104(10):3312-7. PMID: 15284115.
      Citations: 13     Fields:    Translation:Humans
    91. Lauria F, Forconi F. Towards the pharmacotherapy of hairy cell leukaemia. Expert Opin Pharmacother. 2004 Jul; 5(7):1523-33. PMID: 15212603.
      Citations: 2     Fields:    Translation:Humans
    92. Damiani D, Michieli M, Michelutti A, Candoni A, Stocchi R, Masolini P, Geromin A, Michelutti T, Raspadori D, Ippoliti M, Lauria F, Fanin R. Antibody binding capacity for evaluation of MDR-related proteins in acute promyelocytic leukemia: Onset versus relapse expression. Cytometry B Clin Cytom. 2004 May; 59(1):40-5. PMID: 15108169.
      Citations: 2     Fields:    Translation:Humans
    93. Gozzetti A, Tozzuoli D, Crupi R, Gentili S, Raspadori D, Fabbri A, Lauria F. A t(20;21)(q12;q22.3) in a patient with chronic myelocytic leukemia in blastic phase. Cancer Genet Cytogenet. 2004 Apr 01; 150(1):90-1. PMID: 15041233.
      Citations:    Fields:    Translation:HumansCells
    94. Gozzetti A, Tozzuoli D, Crupi R, Pirrotta MT, Bucalossi A, Mazzotta S, Lauria F. A case of adult acute myelocytic leukemia (M5a) with a near-tetraploid karyotype characterized by monosomies 5 and 16. Cancer Genet Cytogenet. 2004 Apr 01; 150(1):88-9. PMID: 15041232.
      Citations:    Fields:    Translation:HumansCells
    95. Forconi F, Capello D, Berra E, Rossi D, Gloghini A, Cerri M, Muti G, Morra E, Paulli M, Magrini U, Lucioni M, Rambaldi A, Lauria F, Carbone A, Stevenson FK, Gaidano G. Incidence of novel N-glycosylation sites in the B-cell receptor of lymphomas associated with immunodeficiency. Br J Haematol. 2004 Mar; 124(5):604-9. PMID: 14871246.
      Citations: 2     Fields:    Translation:HumansCells
    96. Gozzetti A, Tozzuoli D, Crupi R, Fanelli A, Gentili S, Bocchia M, Mazzotta S, Raspadori D, Lauria F. A novel t(6;7)(p24;q21) in a chronic myelocytic leukemia in complete cytogenetic remission after therapy with imatinib mesylate. Cancer Genet Cytogenet. 2004 Jan 15; 148(2):152-4. PMID: 14734229.
      Citations:    Fields:    Translation:HumansCells
    97. Laszlo D, Galieni P, Raspadori D, Tozzi M, Lauria F, Martinelli G. Fludarabine combination regimen severely affected peripheral blood stem cell mobilization. Acta Haematol. 2004; 111(4):228-9. PMID: 15153717.
      Citations: 7     Fields:    Translation:Humans
    98. Fabbri A, Lenoci M, Gozzetti A, Marotta G, Raspadori D, Forconi F, Lauria F. Low-dose oral fludarabine plus cyclophosphamide in elderly patients with chronic lymphoproliferative disorders. Hematol J. 2004; 5(6):472-4. PMID: 15570287.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    99. Gozzetti A, Tozzuoli D, Crupi R, Gentili S, Bocchia M, Raspadori D, Lauria F. Emergence of Ph negative clones in chronic myeloid leukemia (CML) patients in complete cytogenetic remission after therapy with imatinib mesylate (STI). Eur J Haematol. 2003 Oct; 71(4):313-4. PMID: 12950245.
      Citations:    Fields:    Translation:HumansCells
    100. Matteucci C, Galieni P, Leoncini L, Lazzi S, Lauria F, Polito E, Martelli MF, Mecucci C. Typical genomic imbalances in primary MALT lymphoma of the orbit. J Pathol. 2003 Aug; 200(5):656-60. PMID: 12898603.
      Citations: 9     Fields:    Translation:HumansCells
    101. Gozzetti A, Tozzuoli D, Crupi R, Raspadori D, Fabbri A, Lauria F. A case of acute myelogenous leukemia: myelodysplastic syndrome with t(2;11)(p21;q23) without MLL rearrangement. Cancer Genet Cytogenet. 2003 Jul 15; 144(2):177-8. PMID: 12850382.
      Citations: 1     Fields:    Translation:HumansCells
    102. Martelli M, Gherlinzoni F, De Renzo A, Zinzani PL, De Vivo A, Cantonetti M, Falini B, Storti S, Meloni G, Rizzo M, Molinari AL, Lauria F, Moretti L, Lauta VM, Mazza P, Guardigni L, Pescarmona E, Pileri SA, Mandelli F, Tura S. Early autologous stem-cell transplantation versus conventional chemotherapy as front-line therapy in high-risk, aggressive non-Hodgkin's lymphoma: an Italian multicenter randomized trial. J Clin Oncol. 2003 Apr 01; 21(7):1255-62. PMID: 12663712.
      Citations: 20     Fields:    Translation:HumansCTClinical Trials
    103. Bocchia M, Gentili S, Forconi F, le Noci M, Tozzi M, Lauria F. Low-grade non Hodgkin's lymphomas in the elderly: impact of a low-dose fludarabine-based combination regimen (mini-FLEC). Haematologica. 2003 Mar; 88(3):358-60. PMID: 12651282.
      Citations:    Fields:    Translation:Humans
    104. Matteucci C, La Starza R, Crescenzi B, Romoli S, Santoro A, Magrin S, Lauria F, Coco FL, Martelli MF, Mecucci C. Different mechanisms lead to a karyotypically identical t(20;21) in myelodysplastic syndrome and in acute myelocytic leukemia. Cancer Genet Cytogenet. 2003 Jan 01; 140(1):13-7. PMID: 12550752.
      Citations:    Fields:    Translation:HumansCells
    105. Zinzani PL, Martelli M, Bertini M, Gianni AM, Devizzi L, Federico M, Pangalis G, Michels J, Zucca E, Cantonetti M, Cortelazzo S, Wotherspoon A, Ferreri AJ, Zaja F, Lauria F, De Renzo A, Liberati MA, Falini B, Balzarotti M, Calderoni A, Zaccaria A, Gentilini P, Fattori PP, Pavone E, Angelopoulou MK, Alinari L, Brugiatelli M, Di Renzo N, Bonifazi F, Pileri SA, Cavalli F. Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patients. Haematologica. 2002 Dec; 87(12):1258-64. PMID: 12495899.
      Citations: 34     Fields:    Translation:Humans
    106. Raspadori D, Damiani D, Michieli M, Stocchi R, Gentili S, Gozzetti A, Masolini P, Michelutti A, Geromin A, Fanin R, Lauria F. CD56 and PGP expression in acute myeloid leukemia: impact on clinical outcome. Haematologica. 2002 Nov; 87(11):1135-40. PMID: 12414342.
      Citations: 8     Fields:    Translation:Humans
    107. Tosi P, Zamagni E, Cellini C, Ronconi S, Patriarca F, Ballerini F, Musto P, Di Raimondo F, Ledda A, Lauria F, Masini L, Gobbi M, Vacca A, Ria R, Cangini D, Tura S, Baccarani M, Cavo M. Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myeloma. Haematologica. 2002 Apr; 87(4):408-14. PMID: 11940485.
      Citations: 8     Fields:    Translation:HumansCellsCTClinical Trials
    108. Rambaldi A, Lazzari M, Manzoni C, Carlotti E, Arcaini L, Baccarani M, Barbui T, Bernasconi C, Dastoli G, Fuga G, Gamba E, Gargantini L, Gattei V, Lauria F, Lazzarino M, Mandelli F, Morra E, Pulsoni A, Ribersani M, Rossi-Ferrini PL, Rupolo M, Tura S, Zagonel V, Zaja F, Zinzani P, Reato G, Foa R. Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma. Blood. 2002 Feb 01; 99(3):856-62. PMID: 11806987.
      Citations: 24     Fields:    Translation:HumansCellsCTClinical Trials
    109. Marotta G, Lenoci M, Fabbri A, Tozzi M, Lauria F. Efficacy of rituximab in the treatment of refractory chronic lymphocytic leukemia patient with bone marrow aplasia. Hematol J. 2002; 3(6):299-301. PMID: 12522452.
      Citations: 1     Fields:    Translation:Humans